Cross Country Healthcare Stock Forecast, Price & News

Cross Country Healthcare's stock was trading at $7.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CCRN stock has decreased by 21.8% and is now trading at $6.13.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cross Country Healthcare in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Cross Country Healthcare.

Cross Country Healthcare is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Cross Country Healthcare.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) announced its quarterly earnings results on Wednesday, August, 5th. The business services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.20. The business services provider had revenue of $216.78 million for the quarter, compared to the consensus estimate of $198.52 million. Cross Country Healthcare had a positive return on equity of 6.34% and a negative net margin of 2.41%.
View Cross Country Healthcare's earnings history.

Cross Country Healthcare issued an update on its third quarter earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of ($0.06)-($0.02) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.01). The company issued revenue guidance of $170-180 million, compared to the consensus revenue estimate of $194.70 million.

4 equities research analysts have issued 1-year price objectives for Cross Country Healthcare's shares. Their forecasts range from $7.00 to $9.00. On average, they expect Cross Country Healthcare's stock price to reach $7.67 in the next year. This suggests a possible upside of 25.1% from the stock's current price.
View analysts' price targets for Cross Country Healthcare.

Cross Country Healthcare saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 522,000 shares, an increase of 14.0% from the August 15th total of 458,000 shares. Based on an average daily volume of 225,200 shares, the short-interest ratio is presently 2.3 days. Approximately 1.5% of the shares of the company are short sold.
View Cross Country Healthcare's Short Interest.

Some companies that are related to Cross Country Healthcare include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), R1 RCM (RCM), CorVel (CRVL), MEDNAX (MD), The Providence Service (PRSC), Tivity Health (TVTY) and Interpace Diagnostics Group (IDXG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cross Country Healthcare investors own include NVIDIA (NVDA), Energy Transfer LP Unit (ET), Enphase Energy (ENPH), Opko Health (OPK), Overstock.com (OSTK), QUALCOMM (QCOM), Vista Outdoor (VSTO), Twilio (TWLO), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Cross Country Healthcare trades on the NASDAQ under the ticker symbol "CCRN."

Cross Country Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Heartland Advisors Inc. (2.15%), Tocqueville Asset Management L.P. (1.45%), Sei Investments Co. (1.39%), Assenagon Asset Management S.A. (1.15%), Bank of New York Mellon Corp (1.03%) and Jacobs Levy Equity Management Inc. (0.87%). Company insiders that own Cross Country Healthcare stock include Buffy S White, Christopher R Pizzi, Joseph Trunfio, Kevin Cronin Clark, Stephen Alexis Saville, Susan E Ball, Thomas C Dircks, W Larry Cash and William J Burns.
View institutional ownership trends for Cross Country Healthcare.

CCRN stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Goldman Sachs Group Inc., Bank of New York Mellon Corp, Prudential Financial Inc., State of Tennessee Treasury Department, UBS Group AG, Great West Life Assurance Co. Can, and AQR Capital Management LLC.
View insider buying and selling activity for Cross Country Healthcare.

CCRN stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Federated Hermes Inc., Tocqueville Asset Management L.P., Engineers Gate Manager LP, First Republic Investment Management Inc., Marshall Wace LLP, Bank of America Corp DE, and National Investment Services of America LLC. Company insiders that have bought Cross Country Healthcare stock in the last two years include Buffy S White, Joseph Trunfio, Kevin Cronin Clark, Stephen Alexis Saville, Susan E Ball, Thomas C Dircks, W Larry Cash, and William J Burns.
View insider buying and selling activity for Cross Country Healthcare.

Shares of CCRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CCRN stock can currently be purchased for approximately $6.13.

Cross Country Healthcare has a market capitalization of $230.28 million and generates $822.22 million in revenue each year. The business services provider earns $-57,710,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Cross Country Healthcare employs 1,700 workers across the globe.

The official website for Cross Country Healthcare is www.crosscountryhealthcare.com.

Cross Country Healthcare's mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider can be reached via phone at 561-998-2232 or via email at [email protected]